Oct 9, 2026 07:05AM
Oct 8, 2026 04:00AM
Oct 8, 2026 04:00AM
Sep 28, 2026 07:31AM
Sep 28, 2026 07:30AM
Sep 18, 2026 05:17AM
Sep 11, 2026 06:59AM H.C. Wainwright Reiterates Neutral Rating on Biohaven Pharma (BHVN)
Sep 10, 2026 07:26AM
Aug 26, 2026 07:05AM
Aug 26, 2026 02:36AM
Aug 25, 2026 04:44PM
Aug 25, 2026 04:41PM
Aug 10, 2026 04:02PM
Aug 6, 2026 07:00AM Biohaven adds AI investor John Yetimoglu to its board
Aug 6, 2026 07:00AM
Jul 27, 2026 07:01AM
Jul 27, 2026 07:00AM
Jul 20, 2026 07:30AM
Jul 9, 2026 05:01PM
Jul 9, 2026 05:00PM
Jun 29, 2026 07:31AM Biohaven starts Phase 3 trial of BHV-1300 for Graves' disease
Jun 29, 2026 07:30AM
Jun 1, 2026 07:31AM
Jun 1, 2026 07:30AM
May 27, 2026 07:31AM
May 27, 2026 07:30AM
May 26, 2026 07:31AM
May 26, 2026 07:30AM Biohaven Reports New Clinical Data in Epilepsy with Opakalim, a Selective Kv7.2/7.3 Activator, Highlighting Seizure Control and Markedly Differentiated Tolerability Profile
May 4, 2026 04:02PM
Mar 19, 2026 07:30AM
Mar 19, 2026 07:30AM
Mar 2, 2026 04:05PM
Feb 23, 2026 08:43AM
Jan 12, 2026 11:20AM
Jan 12, 2026 11:15AM Biohaven Highlights Portfolio Progress, Positive Early Patient Data from Priority Degrader Programs and Anticipated Milestones at the 44th Annual J.P. Morgan Healthcare Conference
Jan 7, 2026 07:00AM
Dec 24, 2025 01:00PM
Dec 24, 2025 01:00PM
Dec 11, 2025 07:02AM
Dec 11, 2025 07:00AM
Nov 17, 2025 07:38AM
Nov 11, 2025 04:29AM William Blair Reiterates Market Perform Rating on Biohaven Pharmaceutical Holding (BHVN)
Nov 10, 2025 06:58AM
Nov 6, 2025 08:37AM
Nov 5, 2025 04:09PM
Nov 5, 2025 03:33PM
Nov 5, 2025 10:00AM
Nov 5, 2025 08:20AM
Nov 5, 2025 08:19AM William Blair on Biohaven (BHVN): 'Expect Weakness'
Nov 5, 2025 08:17AM

334,273 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All